Plasma exchange in renal disease

Seminars in Dialysis

Volumn 9, Issue 1, 1996, Pages 61-70

  Kaplan, Andre A ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0004964114     PISSN: 08940959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-139x.1996.tb00903.x     Document Type: Article

References (111)

1. Kaplan AA, Halley SE: Plasma exchange with a rotating filter. Kidney Int 38:160-166, 1990
2. Jones JV: The effect of plasmapheresis on therapeutic drugs. Dial Transplant 14:225-226, 1985
3. Stigelman WH, Henry DH, Talbert RL, Townsend RJ: Removal of prednisone and prednisolone by plasma exchange. Clin Pharmacol 3:402-407, 1984
4. Johnson JP, Moore JJ, Austin H III, Balow JE, Antonovych TT, Wilson CB: Therapy of anti-glomerular basement membrane disease: analysis of prognostic significance of clinical, pathologic and treatment factors. Medicine 64:219-227, 1985
5. Savage CO, Pusey CD, Bowman C, Rees AJ, Lockwood CM: Antiglomerular basement membrane antibody-mediated disease in the British isles 1980-4. Br Med J 292:301-304, 1986
6. Simpson IJ, Doak PB, Williams LC, et al.: Plasma exchange in Goodpasture's syndrome. Am J Nephrol 2:301-311, 1982
7. Lockwood CM, Rees AJ, Pearson TA, et al.: Immunosuppression and plasma exchange in the treatment of Goodpasture's syndrome. Lancet i:711-714, 1976
8. Maxwell AP, Nelson WE, Hill CM: Reversal of renal failure in nephritis associated with antibodies to glomerular basement membrane. Br Med J 297:333-334, 1988
9. Mokrzycki MH, Kaplan AA: Therapeutic plasma exchange: Complications and management. Am J Kidney Dis 23:817, 1994
10. Pearl RG, Rosenthal MH: Metabolic alkalosis due to plasmapheresis. Am J Med 79:391-393, 1985
11. Klasa RJ, Abboud RT, Ballon HS, Grossman L: Goodpasture's syndrome: Recurrence after a five-year remission. Am J Med 84:751-755, 1988
12. Buxbaum JN, Chuba JV, Hellman GC, et al.: Monoclonal immunoglobulin deposition disease: Light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Clinical features, immunopathology, and molecular analysis. Ann Intern Med 112:455-464, 1990
13. Solomon A, Weiss DT, Kattine AA: Nephrotoxic potential of bence jones proteins. N Eng J Med 324:1845-1851, 1991
14. Perry MC, Kyle RA: The clinical significance of Bence Jones proteinuria. Mayo Clin Proc 50:234-238, 1975
15. Zucchelli P, Pasquali S, Cagnoli L, Ferrari G: Controlled plasma exchange trial in acute renal failure due to multiple myeloma. Kidney Int 33:1175-1189, 1988
16. Misiani R, Tiraboschi G, Mingardi G, Mecca G: Management of myeloma kidney: An anti-light chain approach. Am J Kidney Dis 10:28-33, 1987
17. Johnson WJ, Kyle RA, Pineda AA, et al.: Treatment of renal failure associated with multiple myeloma. Plasmapheresis, hemodialysis, and chemotherapy. Arch Intern Med 150:863-869, 1990
18. Russell JA, Fitzharris BM, Corringham R, et al.: Plasma exchange v peritoneal dialysis for removing Bence Jones protein. Br Med J 2: 1397, 1978
19. Solomon A, Fahey JL: Plasmapheresis therapy in macroglobulinemia. Ann Intern Med 58:789-500, 1963
20. Lockwood CM: Lymphoma, cryoglobulinemia and renal disease. Kidney Int 16:522-530, 1979
21. Berkman EM: Orlin JB. Use of plasmapheresis and partial plasma exchange in the management of patients with cryoglobulinemia. Transfusion 20:171-178, 1979
22. Geltner D, Kohn RW, Gorevic P, Franklin EC: The effect of combination therapy (steroids, immunosuppressives and plasmapheresis) on 5 mixed cryoglobulinemia patients with renal, neurologic and vascular involvement. Arthritis & Rheumatism 24:1121-1127, 1981
23. D'Amico G, Ferrario F, Colasanti G, Bucci A: Glomerulonephritis in essential mixed cryoglobulinemia, in Proceedings of the XXI Congress of the European Dialysis and Transplant Associated, edited by Davison PJ, Guillon PJ, London, Pitman, 1984, pp. 527-548
24. Evans TW, Nicholls AJ, Shortland JR, et al.: Acute renal failure in essential mixed cryoglobulinemia: Precipitation and reversal by plasma exchange. Clin Nephrol 21:287-293, 1984
25. Ferri C, Moriconi L, Gremignai G, et al.: Treatment of the renal involvement in mixed cryoglobulinemia with prolonged plasma exchange. Nephron 43:246-253, 1986
26. D'Amico G, Colasanti G, Ferrario F, Sinico RA: Renal involvement in essential mixed cryoglobulinemia. Kidney Int 35:1004-1014, 1989
27. Frankel AH, Singer DRJ, Winearls CG, et al.: Type II essential mixed cryoglobulinemia: Presentation, treatment and outcome in 13 patients. Q J Med 82:101-124, 1992
28. Misiani R, Bellavita P, Fenili D, et al.: Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 330:751, 1994
29. Misiani R, Bellavita P, Fenili D, et al.: Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 117: 573-577, 1992
30. Valbonesi M, Garelli S, Montani F, et al.: Management of immune-mediated and paraproteinemic diseases by membrane plasma separation and cascade filtration. Vox Sang 43:91-101, 1982
31. Vibert GJ, Wirtz SA, Smith JW, et al.: Cryofiltration as an alternative to plasma exchange: Plasma macromolecular solute removal without replacement fluids, in Plasmapheresis, edited by Nose Y, Malchesky PS, Smith JW, Cleveland, SAO Press, 1983, pp. 281-287
32. McLeod BC, Sassetti RJ: Plasmapheresis with return of cryoglobulin-depleted autologous plasma (cryoglobulinpheresis) in cryoglobulinemia. Blood 55:866-870, 1980
33. Valbonesi M, Florio G, Montani F, et al.: A method for the study of cryoglobulin solubilization curves at 37 degrees Celsius. Preliminary studies and application to plasma exchange in cryoglobulinemic syndromes. Int J Artif Organs 6:87-90, 1983
34. Cuttner J: Thrombotic thrombocytopenic purpura: a ten year experience. Blood 56:302-306, 1980
35. Bell WR, Braine HG, Ness PM, Kickler TS: Improved survival of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: clinical experience in 108 patients. N Engl J Med 325:398-403, 1991
36. Brekenridge Jr, RL, Solberg LS, Pineda AA, Petitt RM, Dharkar DD: Treatment of thrombotic thrombocytopenic purpura with plasma exchange, antiplatelet agents, corticosteroid and plasma infusion: Mayo Clinic Experience. J Clin Apheresis 1:6-13, 1982
37. Henon P: Treatment of thrombotic thrombocytopenic purpura. First results of a controlled clinical trial. Plasma Ther Transfus Technol 7:101-106, 1986
38. Onundarson PT, Rowe JM, Heal JM, Francis CW: Response to plasma exchange and splenectomy in thrombotic thrombocytopenic purpura: a 10 year experience at a single institution. Arch Inlern Med 152:791-796, 1992
39. Moake JL: TTP-desperation, empiricism, progress (editorial) N Engl J Med 325:426-428, 1991
40. Amorosi EL, Ultman JE: Thrombotic thrombocytopenic purpura: report of 16 cases and review of the literature. Medicine 45:139-159, 1966
41. Byrnes JJ, Moake JL: Thrombotic thrombocytopenic purpura and the haemolytic uraemic syndrome: evolving concepts of pathogenesis and therapy. Clin Haematol 15:413-442, 1986
42. Kwaan HC: Clinicopathologic features of thrombotic thrombocytopenic purpura. Semin Hematol 24:71-51, 1987
43. Lian EC-Y: Pathogenesis of thrombotic thrombocytopenic purpura. Semin Hematol 24:82-100, 1987
44. Remuzzi G: HUS and TTP: Variable expression of a single entity. Kidney Int 32:292-308, 1987
45. Rock GA, Shumak KH, Buskard NA, et al.: Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 325:393-397, 1991
46. Byrnes JJ, Moake JL, Klug P, Penman P: Effectiveness of the cryosupernatant fraction of plasma in the treatment of refractory thrombotic thrombocytopenic purpura. Am J Hematol 34:169-174, 1990
47. Ruggenenti P, Galbusera M, Cornejo RP, et al.: Thrombotic thrombocytopenic purpura: Evidence that infusion rather than removal of plasma induces remission of the disease. Am J Kidney Dis 21:314-318, 1993
48. Shumak KH, Rock GA, Nair RC, and the Canadian Apheresis group: Late relapses in patients successfully treated for thrombotic thrombocytopenic purpura. Ann Intern Med 122:569-572, 1995
49. Apter AJ, Kaplan AA: An approach to immunologic reactions associated with plasma exchange. J Allergy Clin Immunol 90:119, 1992
50. Mokrzycki MH, Rickles FR, Kaplan AA, Kohn OF: Thrombotic thrombocytopenic purpura in pregnancy: successful treatment with plasma exchange. Blood Purif 13:271-281, 1995
51. Kwann HC: Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome in pregnancy. Clin Obst Gyn 28:101-106, 1985
52. May HV, Harbert Jr GM, Thronton Jr WN: Thrombotic thrombocytopenic purpura associated with pregnancy. Am J Obstrect Gynecol 126:452-458,1976
53. Ambrose A, Welham RT, Cefalo RC: Thrombotic thrombocytopenic purpura in early pregnancy. Obst & Gyn 66:267-272, 1985
54. Gerhardt RE, Koethe JD, Ntoso KS et al.: Plasma separation in pregnancy (abstract). Am Soc Artif Intern Organs 20:1, 1991
55. Drummond KN: Hemolytic uremic syndrome-then and now. (editorial) N Eng J Med 312:116-118, 1985
56. Lyman NW, Michaelson R, Viscuso RL, Winn R, Mulgaonkar V, Jacobs MG: Mitomycin-induced hemolytic-uremic syndrome: successful treatment with corticosteroids and intense plasma exchange. Arch Intern Med 143:1617-1618, 1983
57. Aster RH: Quinine sensitivity: a new cause of the hemolytic uremic syndrome. Ann Intern Med 119:243-244, 1993
58. Morel-Maroger L, Kanfer A, Solez K et al.: Prognostic importance of vascular lesions in acute renal failure with microangiopathic hemolytic anemia (hemolytic uremic syndrome): Clinicopathologic study in 20 adults. Kidney Int 15:548-558, 1979
59. Schieppati A, Ruggenenti P, Cornejo RP et al.: Renal function at hospital admission as a prognostic factor in adult hemolytic uremic syndrome. J Am Soc Nephrol 2:1640-1644, 1992
60. Lesesne JB, Rothschild N, Erickson B et al.: Cancer associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry. J Clin Oncol 7:781, 1989
61. Korec S, Schein PS, Smith FP, Neefe JR, Wooley PV, Goldberg RM, Phillips TM: Treatment of cancer-associated hemolytic uremic syndrome with staphylococcal protein A immunoperfusion. J Clin Oncol 4:210-215, 1986
62. Snyder HW, Henry DH, Messerschmidt GL et al.: Minimal toxicity during protein A immunoadsorption treatment of malignant disease: an outpatient therapy. J Clin Apheresis 6:1-10, 1991
63. Cattran DC: Adult hemolytic-uremic syndrome: successful treatment with plasmapheresis. Am J Kidney Dis 3:275-279, 1984
64. Ricker DM, Sharma HM, Nahman Jr S: Acute renal failure with glomerular thrombosis in a patient with chronic sleroderma. Am J Kidney Dis 14:524-526, 1989
65. Martin DL, MacDonald KL, White K, Soler JT, Osterholm MT: The epidemiology and clinical aspects of the hemolytic uremic syndrome in Minnesota. N Engl J Med 323:1161-1167, 1990
66. Rizzoni G, Claris-Appiani A, Edefonti A, Facchin P, Franchini F, Gusmano R, Imbasciati E, Pavanello L, Perfumo F, Ramuzzi G: Plasma infusion for hemolytic-uremic syndrome in children: Results of a multicenter controlled trial. J Pediat 112:284-290, 1988
67. Gianviti A, Perna A, Caringella A, Edefonti A, Penza R, Remuzzi G, Rizzoni G: Plasma exchange in children with hemolytic-uremic syndrome at risk of poor outcome. Am J Kidney Dis 22:264-266, 1993
68. Sheth KJ, Leichter HE, Gill JC, Baumgardt A: Reversal of central nervous system involvement in hemolytic uremic syndrome by use of plasma exchange. Clin Pediat 26:651-656, 1987
69. Angangco R, Thiru S, Esnault VL, et al.: Does truly 'idiopathic' crescentic glomerulonephritis exist? Nephrol Dial Transplant 9:630, 1994
70. Lockwood CM, Rees AJ, Pinching AJ, Pussell B, Sweny P, Uff J, Peters DK: Plasma exchange and immunosuppression in the treatment of fulminating immune-complex crescentric nephritis. Lancet i:63-67, 1977
71. Kincaid-Smith P, D'Apice AJF: Plasmapheresis in rapidly progressive glomerulonephritis. Am J Med 65:564-566, 1978
72. Hind CRK, Paraskevakou H, Lockwood CM, Evans DJ, Peters DK, Rees AJ: Prognosis after immunosuppression of patients with crescentic nephritis requiring dialysis. Lancet i:263-265, 1983
73. Glockner WM, Sieberth HG, Wichmann HE, et al.: Plasma exchange and immunosuppression in rapidly progressive glomerulonephritis: A controlled multi-center study. Clin Nephrol 29:1, 1988
74. Cole E, Cattran D, Magil A, et al.: A prospective randomized trial of plasma exchange as additive therapy in idiopathic crescentic glomerulonephritis. Am J Kidney Dis 20:261-269, 1992
75. Pusey CD, Rees AJ, Evans DJ, et al.: Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies. Kidney Int 40:757, 1991
76. Glassock RJ: Intensive plasma exchange in crescentic glomerulonephritis: Help or no help? Am J Kidney Dis 20:270, 1992
77. Esnault VL, Soleimani B, Keogan MT, et al.: Association of IgM with IgG ANCA in patients presenting with pulmonary hemorrhage. Kidney Int 41:1304, 1992
78. Jones JV, Gumming RH, Bucknall RC, Asplin CM, Fraser ID, Bothamley J, Davis P, Hamblin TJ: Plasmapheresis in the management of acute systemic lupus erythematosus? Lancet i:709-711, 1976
79. Jones JV, Cumming RH, Bacon PA, Evers J, Fraser ID, Bothamley J, Tribe CR, Davis P, Huges GRV: Evidence for a therapeutic effect of plasmapheresis in patients with systemic lupus erythematosus. Quart J Med 192:555-576, 1979
80. Jones JV, Robinson MF, Parciany RK, Layfer LF, McLeod B: Therapeutic plasmapheresis in systemic lupus erythematosus. Arthritis Rheumatism 24:1113-1120, 1981
81. Abdou NI, Lindsley HB, Pollock A, Stechschulte DJ, Wood G: Plasmapheresis in active lupus erythematosus: Effect on clinical, serum and cellular abnormalities, case report. Clin Immunol Immunopath 19:44-54, 1981
82. Leaker BR, Becker GJ, Dowling JP, Kincaid-Smith PS: Rapid improvement in severe lupus glomerular lesions following intensive plasma exchange associated with immunosuppression. Clin Nephrol 25:235-244, 1986
83. Wei N, Klippel JH, Huston DP, Hall RP, Lawley TJ, Balow JE, Steinberg AD, Decker JL: Randomised trial of plasma exchange in mild systemic lupus erythematosus. Lancet i:17-21, 1983
84. French Collaborative Group: A randomized trial of plasma exchange in severe acute systemic lupus erythematosus: methodology and interim analysis. Transfus Technol 6:535-539, 1985
85. Lewis EJ, Hunsicker LG, Lan SP, Rohde RD, Lachin JM, & the Lupus Nephritis Collaborative Study Group: A controlled trial of plasmapheresis therapy in severe lupus nephritis. N Eng J Med 326: 1373-1379, 1992
86. Schlansky R, DeHoratius RJ, Pincus T, Tung KSK: Plasmapheresis in systemic lupus erythematosus: A cautionary note. Arth Rhemat 24:49-53, 1981
87. Euler HH, Schroeder JO, Zeuner RA, Teske E: A randomized trial of plasmapheresis and subsequent pulse cyclophosphamide in severe lupus: design of the LPSG trial. Int J Artif Organs 14:639-646, 1991
88. Schroeder JO, Euler HH, Loffler H: Synchronization of plasmapheresis and pulse cyclophosphamide in several systemic lupus erythematosus. Ann Intern Med 107:344-346, 1987
89. LPSG-Lupus Plasmapheresis Study Group: Circular #1/1995. Clinical Coordinating Center, University of Kiel, 2nd Medical Clinic, Chemnitzstrasse 33, D-24116 Kiel, Germany
90. Euler HH, Schroeder JO, Harten P, et al.: Treatment-free remission in severe systemic lupus erythematosus following synchronization of plasmapheresis with subsequent pulse cyclophosphamide. Arth Rheum 37:1784-1794, 1994
91. Glueck HI, Kant KS, Weiss MA et al.: Thrombosis in systemic lupus erythematosus: Relation to the presence of circulating anticoagulants. Arch Intern Med 145:1389-1395, 1985
92. Kincaid Smith P, Nicholls K: Renal thrombotic microvascular disease associated with LAC. Nephron 54:285-288, 1990
93. Farragia E, Torres VE, Gastineau D et al.: Lupus anticoagulant in SLE: A clinical and renal pathological study. Am J Kidney Dis 20: 463-471, 1992
94. Kincaid-Smith P, Fairley K, Kloss M: Lupus anticoagulant associated with renal thrombotic microangiopathy and pregnancy related renal failure. Quart J Med 258:795-815, 1988
95. Frampton G, Cameron JS, Thorn M, Jones S, Raftery M: Successful removal of antiphospholipid antibody during pregnancy using plasma exchange and low dose prednisolone. Lancet ii: 1023-1024, 1987
96. Fulcher D, Stewart G, Exner T, Trudinger B, Jeremy R: Plasma exchange and the anticardiolipin syndrome in pregnancy. Lancet ii:171, 1989
97. Parke AL, Wilson D, Maier D: The prevalence of antiphospholipid antibodies in women with recurrent spontaneous abortion, women with successful pregnancies and women who have never been pregnant. Arth Rheum 34:1231-1235, 1991
98. Galla JH: IgA nephropathy. Kidney Int 47:377-387, 1995
99. Hene RJ, Kater L: Plasmapheresis in nephritis associated with Henoch-Schonlein Purpura and in primary IgA nephropathy. Plasma Ther Transfus Technol 4:165-173, 1983
100. Coppo R, Basolo B, Roccatello D, Piccoli G: Plasma exchange in primary IgA nephropathy and Henoch-Schonlein Syndrome nephritis. Plasma Ther Transfus Technol 6:705-723, 1985
101. Coppo R, Basolo B, Giachino O, Roccatello D, Lajolo D, Mazzucco G, Amore A, Piccoli G: Plasmapheresis in a patient with rapidly progressive idiopathic IgA nephropathy: removal of IgA-containing circulating immune complexes and clinical recovery. Nephron 40: 488-490, 1985
102. Nicholls K, Becker G, Walker R, Wright C, Kincaid-Smith P: Plasma exchange in progressive IgA nephropathy. J Clin Apheresis 5:128-132, 1990
103. Dantal J, Bigot E, Bogers W, et al.: Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N Engl J Med 330:7-14, 1994
104. Besnier DP, Martin S, Chabannes D, Testa A, Simon P, Esnault VLM: Protein A immunoadsorption reduces proteinuria in patients with nephrotic syndrome and membranous nephropathy (abs). Blood Purif 13:27, 1995
105. Artero ML, Sharma R, Savin VJ, Vincenti F: Focal segmental glomerulosclerosis in renal transplants. Am J Kidney Dis 23:574-581, 1994
106. Kirubakaran MG, Disney APS, Norman J, Pugsley DJ, Mathew TH: A controlled trial of plasmapheresis in the treatment of renal allograft rejection. Transplantation 32:164-165, 1981
107. Allen NH, Dyer P, Geoghegan T, Harris K, Lee HA, Slapak M: Plasma exchange in acute renal allograft rejection. Transplantation 35:425-428, 1983
108. Bonomini V, Vangelista A, Frasca GM, Di Felice A, Liviano D'Arcangelo G: Effects of plasmapheresis in renal transplant rejection: A controlled study. Trans Am Soc Artif Intern Organs 31:698-701, 1985
109. Charpentier BM, Hiesse C, Kriaa F, Rousseau P, Farahmand H, Bismuth A, Fries D: How to deal with the hyperimmunized potential recipients. Kidney Int 42: suppl 38: S-176-181, 1992
110. Hakim RM, Milford E, Himmelfarb J, Wingard R, Lazarus J, Watt RM: Extracorporeal removal of anti-HLA antibodies in transplant candidates. Am J Kidney Dis 16:423-431, 1990
111. Ross CN, Gaskin G, Gregor-Macgregor S, Patel AA, Davey NJ, Lechler RI, Williams G, Rees AJ, Pusey CD: Renal transplantation following immunoadsorption in highly sensitized recipients. Transplantation 55:785-789, 1993